Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
Bavarian Nordic

十一月 2025

十一月 2025的Bavarian Nordic市场份额分析

Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland.
成立年份1994
员工1001 - 5000
年营收$500M - $1B
bavarian-nordic.com
Bavarian Nordic
Bavarian Nordic(包含公司地区分支机构)
  • bavarian-nordic.com
    bavarian-nordic.com
查看更多网站流量和参与度信息

Bavarian Nordic收入截至 十一月 2025为 500M - 1B

Bavarian Nordic主要域名产生的收入

3 年中Bavarian Nordic主要域名的收入

Bavarian Nordic主要域名的收入

bavarian-nordic.combavarian-nordic.com500M - 1B
使用销售情报查看更多信息

Bavarian Nordic热门域名的总访问量

了解Bavarian Nordic市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细
bavarian-nordic.combavarian-nordic.com35.1K
使用销售情报查看更多信息

Bavarian Nordic热门域名的平均访问时长

分析Bavarian Nordic参与度指标。

过去 3 个月的平均访问时长

子公司明细
bavarian-nordic.combavarian-nordic.com00:01:28
使用销售情报查看更多信息

Bavarian Nordic热门域名的平均页面浏览量

了解Bavarian Nordic如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

想要获取更深入的流量洞见?

过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。



Bavarian Nordic 采用的主要技术

这些是排名前 Bavarian Nordic 的顶级域名所使用的网站技术(按行业分列)

电子邮件服务 (3)

Microsoft Exchange Online

Microsoft Exchange Online

付费广告 (2)

DoubleClick

DoubleClick

视听媒体 (2)

商务解决方案 (1)

DocuSign

DocuSign

更多技术

7

查看全部

准备好发现优质潜在客户了吗?

借助 Similarweb 销售情报解决方案,确定任意网站使用了哪些技术来设计完美的销售宣传,并缩短销售周期。


Bavarian Nordic 的新闻与信号

借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。

新闻Bavarian Nordic Group launches Vimkunya chikungunya vaccine.Danish biotech Bavarian Nordic A/S (OMX: BAVA) has announced the official UK launch of the Vimkunya chikungunya vaccine (recombinant, absorbed).
新闻Bavarian Nordic Group is developing non-replicating smallpox vaccine on Jan 1st '03.About its contracts with the U.S. government Since 2003, Bavarian Nordic has worked with the U.S. government on the development, manufacturing and supply of a non-replicating smallpox vaccine to ensure all populations can be protected from smallpox and mpox, including people with weakened immune systems who are at high risk of adverse reactions to traditional smallpox vaccines, which are based on replicating vaccinia virus strains.
新闻Bavarian Nordic Group launched vaccine in the UK on May 2nd '25.Bavarian Nordic is targeting launch of the vaccine in the UK during the summer of 2025.

查看 Bavarian Nordic 的所有信号

让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。